I disagree. We have nearly twenty years of research on the first SARS-Corona virus. We know a great deal about that virus, and were conducting vaccine studies before the epidemic went bye-bye and government funding (and the market) dried up. SARS-CoV-1 and SARS-Cov-2 are closely related, giving us a wealth of existing learnings and a hudge step up. We know that most folks will not be significantly affected by it. We know it's cell surface target and understand how to neutralize it. We know that it's not a difficult agent to combat. That there are over seventy candidate vaccines demonstrates how much we know about this bugger. Therapeutics for infected people I don't know so much about.
Bookmarks